Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention—A Report from the 2021 National Heart, Lung, and Blood Institute Workshop
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The National Heart, Lung, and Blood Institute (NHLBI) convened a workshop of international experts to discuss new research opportunities for the prevention, detection, and intervention of myocarditis in May 2021. These experts reviewed the current state of science and identified key gaps and opportunities in basic, diagnostic, translational, and therapeutic frontiers to guide future research in myocarditis. In addition to addressing community-acquired myocarditis, the workshop also focused on emerging causes of myocarditis including immune checkpoint inhibitors and SARS-CoV-2 related myocardial injuries and considered the use of systems biology and artificial intelligence methodologies to define workflows to identify novel mechanisms of disease and new therapeutic targets. A new priority is the investigation of the relationship between social determinants of health (SDoH), including race and economic status, and inflammatory response and outcomes in myocarditis. The result is a proposal for the reclassification of myocarditis that integrates the latest knowledge of immunological pathogenesis to refine estimates of prognosis and target pathway-specific treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COVID-19-associated myocarditis, where cardiac damage and inflammation are indirectly caused by immune dysregulation”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the presence of viral genomes in endomyocardial biopsies (EMBs) may not consistently correlate with active infection”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308 · cited 1×
“3 to 1% of ICI- treated cancer patients with up to a 50% reported mortality [11,12].”
BackgroundCardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059
Self-citationCells of the adult human heart
Litviňuková, M., Talavera-López, C., Maatz, H., Reichart, D., Worth, C. L., Lindberg, E. L., Kanda, M., Polanski, K., Heinig, M., Lee, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2797-4 · Cited by 1,729 · cited 1×
“The heart consists of a complex cellular network including myocytes, fibroblasts, and immune cells with molecular and functional relationships [96].”
BackgroundEpelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.019 · Cited by 1,494
Self-citationHavranek, E. P., Mujahid, M. S., Barr, D. A., Blair, I. V., Cohen, M. S., Cruz-Flores, S., Davey-Smith, G., Dennison-Himmelfarb, C. R., Lauer, M. S., Lockwood, D. W., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000228 · Cited by 1,472 · cited 1×
“The impact of social determinants of health (SDoH), including systems to identify and treat illnesses, socioeconomic position, and race, is established for traditional risk factors and outcomes in cardiovascular diseases [99].”
BackgroundMyocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217 · cited 2×
“Enteroviruses, herpesviruses, and adenoviruses are commonly found in myocarditis biopsies [4].”
BackgroundSelf-citationMacrophages Facilitate Electrical Conduction in the Heart
Hulsmans, M., Clauss, S., Xiao, L., Aguirre, A. D., King, K. R., Hanley, A., Hucker, W. J., Wülfers, E. M., Seemann, G., Courties, G., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.050 · Cited by 1,011
Self-Renewing Resident Cardiac Macrophages Limit Adverse Remodeling Following Myocardial Infarction
Dick, S. A., Macklin, J. A., Nejat, S., Momen, A., Clemente-Casares, X., Althagafi, M. G., Chen, J., Kantores, C., Hosseinzadeh, S., Aronoff, L., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0272-2 · Cited by 883
Lavine, K. J., Epelman, S., Uchida, K., Weber, K. J., Nichols, C. G., Schilling, J. D., Ornitz, D. M., Randolph, G. J., & Mann, D. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406508111 · Cited by 818
Self-citationAmmirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007405 · Cited by 811 · cited 1×
“For example, hemodynamic compromise with cardiogenic shock, the presence of ventricular arrhythmias, high-grade heart block, female sex and lower left and right ventricular systolic function increase the risk of subsequent death or heart transplantation [97,98].”
BackgroundSelf-citationTargeting cardiac fibrosis with engineered T cells
Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1546-z · Cited by 801
A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
Nicolás-Ávila, J. A., Lechuga-Vieco, A. V., Esteban-Martínez, L., Sánchez-Díaz, M., Díaz-García, E., Santiago, D. J., Rubio-Ponce, A., Li, J. L., Balachander, A., Quintana, J. A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.031 · Cited by 762
Idiopathic Giant-Cell Myocarditis — Natural History and Treatment
Cooper, L. T., Berry, G. J., & Shabetai, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362603 · Cited by 757
Bajpai, G., Bredemeyer, A., Li, W., Zaitsev, K., Koenig, A. L., Lokshina, I., Mohan, J., Ivey, B., Hsiao, H.-M., Weinheimer, C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314028 · Cited by 751
The human heart contains distinct macrophage subsets with divergent origins and functions
Bajpai, G., Schneider, C., Wong, N., Bredemeyer, A., Hulsmans, M., Nahrendorf, M., Epelman, S., Kreisel, D., Liu, Y., Itoh, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0059-x · Cited by 712
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., Grinberg, T., Auster, O., Dagan, N., Balicer, R. D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110737 · Cited by 613 · cited 2×
“Although 76% or more of these cases have little to no impairment of left ventricle systolic function and patients recover within days, understanding the mechanism of this injury is of great interest in the COVID-19 pandemic [19].”
BackgroundMyocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., Olsha-Castell, S., Arad, D., Hasin, T., Levi, N., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2109730 · Cited by 599
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., Loran, D., Hrncir, D., Herring, K., Platzer, M., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.2833 · Cited by 536
Self-citationEchocardiographic Assessment of Myocardial Strain
Gorcsan, J., & Tanaka, H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.038 · Cited by 468
The influence of sex and gender on the immune response
Oertelt-Prigione, S. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.022 · Cited by 459
Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure
Park, J. J., Park, J.-B., Park, J.-H., & Cho, G.-Y. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.064 · Cited by 400
The plasticity of human Treg and Th17 cells and its role in autoimmunity
Kleinewietfeld, M., & Hafler, D. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.009 · Cited by 389
COVID-19 and Cardiovascular Disease: From Bench to Bedside
Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T., Harding, C. V., Kwon, D. H., Singh, T., Tilton, J. C., Tsai, E. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.317997 · Cited by 373
Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334 · cited 9×
“For example, CCR2+Ly6Chi inflammatory macrophages were shown to drive post-myocarditis fibrosis and development of dilated cardiomyopathy (DCM) [35].”
BackgroundMethodMyopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military Personnel
Halsell, J. S. (2003) · JAMA · doi:10.1001/jama.289.24.3283 · Cited by 333
Kodama, M., Matsumoto, Y., Fujiwara, M., Masani, F., Izumi, T., & Shibata, A. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90039-s · Cited by 330 · cited 4×
“Eosinophilic myocarditis mouse models as EAM in mice that overexpress IL-5 under the CD3δ promoter or mice deficient in both IL-17A and IFNγ (IL17A-/-IFNγ-/-) have been also described [80].”
BackgroundInfluentialSex and Gender Differences in Myocarditis and Dilated Cardiomyopathy
Fairweather, D., Cooper, L. T., & Blauwet, L. A. (2013) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.003 · Cited by 325 · cited 7×
“For example, CCR2+Ly6Chi inflammatory macrophages were shown to drive post-myocarditis fibrosis and development of dilated cardiomyopathy (DCM) [35].”
BackgroundSelf-citationHalushka, M. K., & Vander Heide, R. S. (2021) · Cardiovascular Pathology · doi:10.1016/j.carpath.2020.107300 · Cited by 307 · cited 1×
“However, classic lymphocytic myocarditis is rarely found in COVID-19 autopsies [9].”
BackgroundWei, S. C., Meijers, W. C., Axelrod, M. L., Anang, N.-A. A. S., Screever, E. M., Wescott, E. C., Johnson, D. B., Whitley, E., Lehmann, L., Courand, P.-Y., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0856 · Cited by 290 · cited 1×
“Pharmacological models and genetic mouse models of myocarditis induced by ICIs have also been in development; such models are essential for understanding the pathogenesis of this rare but serious complication [83].”
BackgroundPD-1 deficiency results in the development of fatal myocarditis in MRL mice
Wang, J., Okazaki, I.-M., Yoshida, T., Chikuma, S., Kato, Y., Nakaki, F., Hiai, H., Honjo, T., & Okazaki, T. (2010) · International Immunology · doi:10.1093/intimm/dxq026 · Cited by 270 · cited 1×
“In addition, spontaneous myocarditis develops in PD-1 knockout (KO) mice on the MLR-Faslpr/lpr background [82].”
BackgroundMicrothrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study
Pellegrini, D., Kawakami, R., Guagliumi, G., Sakamoto, A., Kawai, K., Gianatti, A., Nasr, A., Kutys, R., Guo, L., Cornelissen, A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051828 · Cited by 270 · cited 1×
“Alternative mechanisms of injury such as platelet-rich microthrombi and direct proarrhythmic effects of viral proteins have been reported in COVID-19 decedents [10].”
BackgroundT-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17
Rangachari, M., Mauermann, N., Marty, R. R., Dirnhofer, S., Kurrer, M. O., Komnenovic, V., Penninger, J. M., & Eriksson, U. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052222 · Cited by 264
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Gil-Cruz, C., Perez-Shibayama, C., De Martin, A., Ronchi, F., van der Borght, K., Niederer, R., Onder, L., Lütge, M., Novkovic, M., Nindl, V., et al. (2019) · Science · doi:10.1126/science.aav3487 · Cited by 260 · cited 1×
“In addition, environmental influences can promote inflammatory responses, especially in genetically susceptible individuals, as recently demonstrated in the activation of cardiac myosin-specific T-helper cells in the intestine by a mimic peptide from a common commensal Bacteroides species in patients with particular H…”
BackgroundCardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230 · cited 9×
“For example, CCR2+Ly6Chi inflammatory macrophages were shown to drive post-myocarditis fibrosis and development of dilated cardiomyopathy (DCM) [35].”
BackgroundSelf-citationFairweather, D., Yusung, S., Frisancho, S., Barrett, M., Gatewood, S., Steele, R., & Rose, N. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4731 · Cited by 229
Cardiac Autoimmunity: Myocarditis
Bracamonte-Baran, W., & Čiháková, D. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-57613-8_10 · Cited by 228 · cited 1×
“The pathogenic process of myocarditis is often driven by activated immune cells, cytokines, and chemokines [32].”
BackgroundSelf-citationMyocardial Tissue Characterization and Fibrosis by Imaging
Karamitsos, T. D., Arvanitaki, A., Karvounis, H., Neubauer, S., & Ferreira, V. M. (2020) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2019.06.030 · Cited by 228
Göser, S., Andrassy, M., Buss, S. J., Leuschner, F., Volz, C. H., Öttl;, R., Zittrich;, S., Blaudeck, N., Hardt, S. E., Pfitzer, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.635664 · Cited by 224 · cited 1×
“Troponin-induced myocarditis has also been developed [79].”
Genetics of dilated cardiomyopathy: practical implications for heart failure management
Rosenbaum, A. N., Agre, K. E., & Pereira, N. L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0284-0 · Cited by 224
Myocarditis after Covid-19 mRNA Vaccination
Verma, A. K., Lavine, K. J., & Lin, C.-Y. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2109975 · Cited by 215
Frisancho-Kiss, S., Davis, S. E., Nyland, J. F., Frisancho, J. A., Cihakova, D., Barrett, M. A., Rose, N. R., & Fairweather, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6710 · Cited by 212
Noutsias, M., Fechner, H., de Jonge, H., Wang, X., Dekkers, D., Houtsmuller, A. B., Pauschinger, M., Bergelson, J., Warraich, R., Yacoub, M., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.275 · Cited by 203
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Gatewood, S. J. L., Njoku, D. B., & Rose, N. R. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63241-5 · Cited by 198
A Novel Circulating Noncoding Small RNA for the Detection of Acute Myocarditis
Blanco-Domínguez, R., Sánchez-Díaz, R., de la Fuente, H., Jiménez-Borreguero, L. J., Matesanz-Marín, A., Relaño, M., Jiménez-Alejandre, R., Linillos-Pradillo, B., Tsilingiri, K., Martín-Mariscal, M. L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2003608 · Cited by 196 · cited 2×
“Males in both mice and human have elevated levels of CD11b+ immune cells, sera soluble suppression of tumorigenesis-2 (sST2) and Th17-type immune responses during myocarditis [52,61,68,69].”
BackgroundAdverse Events Associated With Smallpox Vaccination in the United States, January-October 2003
Casey, C. G. (2005) · JAMA · doi:10.1001/jama.294.21.2734 · Cited by 192
Gorbea, C., Makar, K. A., Pauschinger, M., Pratt, G., Bersola, J. L. F., Varela, J., David, R. M., Banks, L., Huang, C.-H., Li, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047464 · Cited by 189
Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy
Wu, L., Ong, S., Talor, M. V., Barin, J. G., Baldeviano, G. C., Kass, D. A., Bedja, D., Zhang, H., Sheikh, A., Margolick, J. B., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132126 · Cited by 181 · cited 9×
“For example, CCR2+Ly6Chi inflammatory macrophages were shown to drive post-myocarditis fibrosis and development of dilated cardiomyopathy (DCM) [35].”
BackgroundSelf-citationFuse, K., Chan, G., Liu, Y., Gudgeon, P., Husain, M., Chen, M., Yeh, W.-C., Akira, S., & Liu, P. P. (2005) · Circulation · doi:10.1161/circulationaha.105.536433 · Cited by 181 · cited 1×
“The first model can induce severe myocarditis and death of the infected mice within the first week, while the second model utilizes less severe heart-passaged CVB3 that allows a study of dilated cardiomyopathy phase [73,74].”
Self-citationCunningham, M. W., Antone, S. M., Gulizia, J. M., McManus, B. M., Fischetti, V. A., & Gauntt, C. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1320 · Cited by 176 · cited 1×
“The precise mechanism by which acute viral infection progresses to chronic autoimmune myocarditis is incompletely characterized, but may involve molecular mimicry between viral and cardiac antigens as well as potential bystander effects during antigen presentation [30,31].”
BackgroundSelf-citationAfanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M. J., Schofield, B. H., Hill, S. L., & Rose, N. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61685-9 · Cited by 175
Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis
Sonderegger, I., Röhn, T. A., Kurrer, M. O., Iezzi, G., Zou, Y., Kastelein, R. A., Bachmann, M. F., & Kopf, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200636484 · Cited by 167
Carlquist, J. F., Menlove, R. L., Murray, M. B., O'Connell, J. B., & Anderson, J. L. (1991) · Circulation · doi:10.1161/01.cir.83.2.515 · Cited by 160 · cited 2×
“Polymorphisms in MHC are among the strongest predisposing genetic factors in autoimmune diseases in general, and serologic and molecular analyses suggest a significant, but inconsistent correlation of DCM with MHC class II antigens, particularly HLA-DR4, DQ5, and DQ8 [84,85].”
BackgroundHuber, S. A., Gauntt, C. J., & Sakkinen, P. A. (1998) · Advances in virus research · doi:10.1016/s0065-3527(08)60783-6 · Cited by 160 · cited 1×
“The first model can induce severe myocarditis and death of the infected mice within the first week, while the second model utilizes less severe heart-passaged CVB3 that allows a study of dilated cardiomyopathy phase [73,74].”
The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children
Porritt, R. A., Binek, A., Paschold, L., Rivas, M. N., McArdle, A., Yonker, L. M., Alter, G., Chandnani, H. K., Lopez, M., Fasano, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151520 · Cited by 156
Čiháková, D., Barin, J. G., Afanasyeva, M., Kimura, M., Fairweather, D., Berg, M. G., Talor, M. V., Baldeviano, G. C., Frisancho‐Kiss, S., Gabrielson, K. L., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070207 · Cited by 150
Self-citationVerdonschot, J., Hazebroek, M., Merken, J., Debing, Y., Dennert, R., Brunner-La Rocca, H.-P., & Heymans, S. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.665 · Cited by 150 · cited 1×
“can persist in the cardiomyocytes with an unknown consequence to myocarditis pathogenesis [5].”
BackgroundAfanasyeva, M., Wang, Y., Kaya, Z., Stafford, E. A., Dohmen, K. M., Sadighi Akha, A. A., & Rose, N. R. (2001) · Circulation · doi:10.1161/hc5001.100629 · Cited by 148
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018
Su, J. R., McNeil, M. M., Welsh, K. J., Marquez, P. L., Ng, C., Yan, M., & Cano, M. V. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.12.046 · Cited by 143
Xiong, D., Lee, G.-H., Badorff, C., Dörner, A., Lee, S., Wolf, P. L., & Knowlton, K. U. (2002) · Nature Medicine · doi:10.1038/nm737 · Cited by 141 · cited 4×
“Elimination of the Coxsackievirus-Adenovirus Receptor (CAR) in adult hearts has been shown to block virus entry into the heart and to prevent contractile dysfunction.”
BackgroundInfluentialBearse, M., Hung, Y. P., Krauson, A. J., Bonanno, L., Boyraz, B., Harris, C. K., Helland, T. L., Hilburn, C. F., Hutchison, B. M., Jobbagy, S., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00790-1 · Cited by 124 · cited 1×
“The presence of SARS-CoV-2 in the heart is associated with increased myeloid cells density [7,8].”
BackgroundCoronado, M. J., Brandt, J. E., Kim, E., Bucek, A., Bedja, D., Abston, E. D., Shin, J., Gabrielson, K. L., Mitzner, W., & Fairweather, D. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00783.2011 · Cited by 116
The application of big data to cardiovascular disease: paths to precision medicine
Leopold, J. A., Maron, B. A., & Loscalzo, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129203 · Cited by 111
Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart
Adamo, L., Resende, C. R., Lin, C., Evans, S., Williams, J. W., Dun, H., Li, W., Mpoy, C., Andhey, P. S., Rogers, B. E., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134700 · Cited by 109 · cited 2×
“Similarly, B cells are heterogeneous and have both antibody-dependent and antibodyindependent functions [55].”
BackgroundSelf-citationMamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 107
Self-citationHuber, S. A., & Cunningham, M. W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3528 · Cited by 104 · cited 1×
“The precise mechanism by which acute viral infection progresses to chronic autoimmune myocarditis is incompletely characterized, but may involve molecular mimicry between viral and cardiac antigens as well as potential bystander effects during antigen presentation [30,31].”
BackgroundSelf-citationGenetic complexity of autoimmune myocarditis
Li, H. S., Ligons, D. L., & Rose, N. R. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.11.010 · Cited by 102
Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy
Diny, N. L., Baldeviano, G. C., Talor, M. V., Barin, J. G., Ong, S., Bedja, D., Hays, A. G., Gilotra, N. A., Coppens, I., Rose, N. R., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161702 · Cited by 99 · cited 2×
“The EAM is induced by immunization with an alpha myocyte heavy chain (αMHC) peptide emulsified in an adjuvant such as complete Freund’s adjuvant in susceptible strains of mice, such as A/J, Balb/c and SWXJ mice [33,34,46,53,77,78] (Figure 2).”
BackgroundMethodSelf-citationElevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis
Coronado, M. J., Bruno, K. A., Blauwet, L. A., Tschöpe, C., Cunningham, M. W., Pankuweit, S., van Linthout, S., Jeon, E., McNamara, D. M., Krejčí, J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.008968 · Cited by 99 · cited 9×
“For example, CCR2+Ly6Chi inflammatory macrophages were shown to drive post-myocarditis fibrosis and development of dilated cardiomyopathy (DCM) [35].”
BackgroundInfluentialSelf-citationAnimal Models for Autoimmune Myocarditis and Autoimmune Thyroiditis
Čiháková, D., Sharma, R. B., Fairweather, D., Afanasyeva, M., & Rose, N. R. (2004) · Autoimmunity · doi:10.1385/1-59259-805-6:175 · Cited by 98 · cited 1×
“The EAM is induced by immunization with an alpha myocyte heavy chain (αMHC) peptide emulsified in an adjuvant such as complete Freund’s adjuvant in susceptible strains of mice, such as A/J, Balb/c and SWXJ mice [33,34,46,53,77,78] (Figure 2).”
MethodSelf-citationLyden, D. C., Olszewski, J., Feran, M., Job, L. P., & Huber, S. A. (1987) · PubMed Central · Cited by 97
Myopathic Cardiac Genotypes Increase Risk for Myocarditis
Kontorovich, A. R., Patel, N., Moscati, A., Richter, F., Peter, I., Purevjav, E., Selejan, S. R., Kindermann, I., Towbin, J. A., Bohm, M., et al. (2021) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2021.06.001 · Cited by 95
Baritussio, A., Schiavo, A., Basso, C., Giordani, A. S., Cheng, C., Pontara, E., Cattini, M. G., Bison, E., Gallo, N., De Gaspari, M., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2496 · Cited by 90 · cited 1×
“For example, hemodynamic compromise with cardiogenic shock, the presence of ventricular arrhythmias, high-grade heart block, female sex and lower left and right ventricular systolic function increase the risk of subsequent death or heart transplantation [97,98].”
BackgroundHuber, S. A., Kupperman, J., & Newell, M. K. (1999) · Lupus · doi:10.1177/096120339900800511 · Cited by 90
Hormonal Regulation of CD4+T-Cell Responses in Coxsackievirus B3-Induced Myocarditis in Mice
Huber, S. A., Kupperman, J., & Newell, M. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4689-4695.1999 · Cited by 88
Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies
Mascaro-Blanco, A., Alvarez, K., Yu, X., Lindenfeld, J., Olansky, L., Lyons, T., Duvall, D., Heuser, J. S., Gosmanova, A., Rubenstein, C. J., et al. (2008) · Autoimmunity · doi:10.1080/08916930802031579 · Cited by 86
Self-citationPredictors of Mortality in Patients With Biopsy‐Proven Viral Myocarditis: 10‐Year Outcome Data
Greulich, S., Seitz, A., Müller, K. A. L., Grün, S., Ong, P., Ebadi, N., Kreisselmeier, K. P., Seizer, P., Bekeredjian, R., Zwadlo, C., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015351 · Cited by 86
The Cardiac Microenvironment Instructs Divergent Monocyte Fates and Functions in Myocarditis
Hou, X., Chen, G., Bracamonte-Baran, W., Choi, H. S., Diny, N. L., Sung, J., Hughes, D., Won, T., Wood, M. K., Talor, M. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.007 · Cited by 83
Self-citationCOVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism
Fox, S., Falgout, L. M., & Heide, R. S. V. (2021) · Cardiovascular Pathology · doi:10.1016/j.carpath.2021.107361 · Cited by 81 · cited 1×
“The presence of SARS-CoV-2 in the heart is associated with increased myeloid cells density [7,8].”
BackgroundPediatric and adult dilated cardiomyopathy represent distinct pathological entities
Patel, M. D., Jayaram, M., Schneider, C., Bajpai, G., Purevjav, E., Canter, C. E., Towbin, J. A., Bredemeyer, A. L., & Lavine, K. J. (2017) · JCI Insight · doi:10.1172/jci.insight.94382 · Cited by 80
Clemente‐Casares, X., Hosseinzadeh, S., Barbu, I., Dick, S. A., Macklin, J. A., Wang, Y., Momen, A., Kantores, C., Aronoff, L., Farno, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.011 · Cited by 75
Li, Y., Heuser, J. S., Kosanke, S. D., Hemric, M., & Cunningham, M. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3225 · Cited by 73 · cited 4×
“Eosinophilic myocarditis mouse models as EAM in mice that overexpress IL-5 under the CD3δ promoter or mice deficient in both IL-17A and IFNγ (IL17A-/-IFNγ-/-) have been also described [80].”
BackgroundSelf-citationLt, C., Berry, G. J., Rizeq, M. N., & SCHROEDER, J. S. (1995) · PubMed · Cited by 73
Piriou*, N., Marteau, L., Kyndt, F., Serfaty, J. M., Toquet, C., Le Gloan, L., Warin-Fresse, K., Guijarro, D., Le Tourneau, T., Conan, E., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12686 · Cited by 72
Diny, N. L., Hou, X., Barin, J. G., Chen, G., Talor, M. V., Schaub, J., Russell, S. D., Klingel, K., Rose, N. R., & Čiháková, D. (2016) · European Journal of Immunology · doi:10.1002/eji.201646557 · Cited by 70 · cited 1×
“Similar to the response to Th17, in Th2 driven myocarditis, fibroblasts also play a major role in the chemotaxis of the effector cells, eosinophils, by the production of chemokines eotaxins [54].”
BackgroundSelf-citationAbston, E. D., Barin, J. G., Cihakova, D., Bucek, A., Coronado, M. J., Brandt, J. E., Bedja, D., Kim, J. B., Georgakopoulos, D., Gabrielson, K. L., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963769 · Cited by 69 · cited 1×
“Overreactive innate immune response can contribute to cardiac inflammation as well, especially when pericarditis is also present, as was shown by IL-33 induced pericarditis [59,60].”
BackgroundMyocarditis and pericarditis are rare following live viral vaccinations in adults
Kuntz, J., Crane, B., Weinmann, S., & Naleway, A. L. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.030 · Cited by 64
IFITM3: How genetics influence influenza infection demographically
Wellington, D., Laurenson‐Schafer, H., Abdel‐Haq, A., & Dong, T. (2019) · Biomedical Journal · doi:10.1016/j.bj.2019.01.004 · Cited by 64
Fatal Eosinophilic Myocarditis Develops in the Absence of IFN-γ and IL-17A
Barin, J. G., Baldeviano, G. C., Talor, M. V., Wu, L., Ong, S., Fairweather, D., Bedja, D., Stickel, N. R., Fontes, J. A., Cardamone, A. B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301282 · Cited by 63
Self-citationHerda, L. R., Trimpert, C., Nauke, U., Landsberger, M., Hummel, A., Beug, D., Kieback, A. G., Dörr, M., Empen, K., Knebel, F., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.01.012 · Cited by 61
Gräni, C., Bière, L., Eichhorn, C., Kaneko, K., Agarwal, V., Aghayev, A., Steigner, M. L., Blankstein, R., Jerosch‐Herold, M., & Kwong, R. Y. K. (2019) · International journal of cardiac imaging · doi:10.1007/s10554-019-01552-6 · Cited by 61
Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression
KONG, G., MADDEN, B., SPYROU, N., POMERANCE, A., MITCHELL, A., & YACOUB, M. (1991) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059938 · Cited by 57
Giant cell myocarditis: Diagnosis and treatment
Cooper, L. T., & ElAmm, C. (2012) · Herz · doi:10.1007/s00059-012-3658-1 · Cited by 55
Roberts, B. J., Moussawi, M., & Huber, S. A. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.06.005 · Cited by 54
Giant cell myocarditis: first report of disease recurrence in the transplanted heart.
Gries, W., Farkas, D., Winters, G. L., & Costanzo-Nordin, M. R. (1992) · PubMed · Cited by 54
Anzai, A., Mindur, J. E., Halle, L., Sano, S., Choi, J. L., He, S., McAlpine, C. S., Chan, C. T., Kahles, F., Valet, C., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180722 · Cited by 53
Management of Cardiac Sarcoidosis in 2020
Gilotra, N. A., Okada, D. R., Sharma, A., & Chrispin, J. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.09 · Cited by 53 · cited 1×
“In addition, sarcoidosis, an inflammatory granulomatous disease, can affect the heart [29].”
BackgroundAder, F., Surget, E., Charron, P., Redheuil, A. B., Zouaghi, A., Maltret, A., Marijon, É., Denjoy, I., Hermida, A., Fressart, V., et al. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002744 · Cited by 52
Buxton, D. B., Antman, M., Danthi, N., Dilsizian, V., Fayad, Z. A., Garcia, M. J., Jaff, M. R., Klimas, M., Libby, P., Nahrendorf, M., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.000943 · Cited by 49
Self-citationSusceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4+ T cells
Chen, P., Baldeviano, G. C., Ligons, D. L., Talor, M. V., Barin, J. G., Rose, N. R., & Cihakova, D. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2012.04598.x · Cited by 48
Self-citationCaspar, T., Fichot, M., Ohana, M., Ghannudi, S. E., Morel, O., & Ohlmann, P. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.04.002 · Cited by 47
Network medicine in Cardiovascular Research
Lee, L. Y.-H., Pandey, A. K., Maron, B. A., & Loscalzo, J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa321 · Cited by 47
Myocarditis and primary Sjogren's syndrome
Levin, M.-D., Zoet-Nugteren, S., & Markusse, H. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02251-5 · Cited by 44 · cited 1×
“Myocarditis is associated with high morbidity when associated with systemic autoimmune diseases, such as Sjögren’s disease, systemic lupus erythematous, and vasculitis [27,28].”
BackgroundInnate Lymphoid Cells Play a Pathogenic Role in Pericarditis
Choi, H. S., Won, T., Hou, X., Chen, G., Bracamonte-Baran, W., Talor, M. V., Jurčová, I., Szárszoi, O., Čurnova, L., Stříž, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.040 · Cited by 43 · cited 2×
“Interestingly, IL-33 induced perimyocarditis can develop by activation of innate lymphoid (ILC) cells without contribution of adaptive immune system [60].”
BackgroundSelf-citationPathogenic IL‐23 signaling is required to initiate GM‐CSF‐driven autoimmune myocarditis in mice
Wu, L., Diny, N. L., Ong, S., Barin, J. G., Hou, X., Rose, N. R., Talor, M. V., & Čiháková, D. (2016) · European Journal of Immunology · doi:10.1002/eji.201545924 · Cited by 42 · cited 1×
“The EAM is induced by immunization with an alpha myocyte heavy chain (αMHC) peptide emulsified in an adjuvant such as complete Freund’s adjuvant in susceptible strains of mice, such as A/J, Balb/c and SWXJ mice [33,34,46,53,77,78] (Figure 2).”
MethodSelf-citationSugahara, M., Kagiyama, N., Hasselberg, N. E., Blauwet, L. A., Briller, J. E., Cooper, L. T., Fett, J. D., Hsich, E., Wells, G., McNamara, D. M., et al. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.07.018 · Cited by 39
Baumer, Y., Farmer, N. M., Premeaux, T. A., Wallen, G. R., & Powell‐Wiley, T. M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.559312 · Cited by 39 · cited 1×
“More recently, SDoH have also been implicated in altering the patients’ immune function and inflammatory response, and these observations have driven new hypotheses regarding disparities in COVID-19 related outcomes [100].”
ResultMyocarditis as a prognostic indicator in systemic lupus erythematosus
Busteed, S., Sparrow, P. J., Molloy, C., & Molloy, M. G. (2004) · Postgraduate Medical Journal · doi:10.1136/pgmj.2003.012450 · Cited by 37 · cited 1×
“Myocarditis is associated with high morbidity when associated with systemic autoimmune diseases, such as Sjögren’s disease, systemic lupus erythematous, and vasculitis [27,28].”
BackgroundMoreira, H. T., Volpe, G. J., Marin‐Neto, J. A., Nwabuo, C. C., Ambale‐Venkatesh, B., Gali, L. G., de Almeida-Filho, O. C., Romano, M. M. D., Pazin‐Filho, A., Maciel, B. C., et al. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.01.010 · Cited by 24
HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy
Martinetti, M., Dugoujon, J., Caforio, A. L. P., Schwarz, G., Gavazzi, A., Graziano, G., Arbustini, E., Lorini, R., McKenna, W. J., Bottazzo, G. F., et al. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90105-v · Cited by 23 · cited 2×
“Polymorphisms in MHC are among the strongest predisposing genetic factors in autoimmune diseases in general, and serologic and molecular analyses suggest a significant, but inconsistent correlation of DCM with MHC class II antigens, particularly HLA-DR4, DQ5, and DQ8 [84,85].”
BackgroundGürdoğan, M., & Yalta, K. (2020) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2020.79584 · Cited by 21 · cited 1×
“3 to 1% of ICI- treated cancer patients with up to a 50% reported mortality [11,12].”
BackgroundSystems Genetics for Mechanistic Discovery in Heart Diseases
Rau, C. D., Lusis, A. J., & Wang, Y. (2020) · Circulation Research · doi:10.1161/circresaha.119.315863 · Cited by 20
Giant cell myocarditis in a transplanted heart
Grant, S. C. D. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.10.1437 · Cited by 16
Characterization of a mouse model of hypereosinophilia-associated heart disease
Prows, D. R., Klingler, A. M., Gibbons, W. J., Homan, S. M., & Zimmermann, N. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2019 · Cited by 15 · cited 1×
“cently, a spontaneous mouse mutant displays hypereosinophilia and develops eosinophilic myocarditis that results in sudden, premature death of the animals [81].”
BackgroundBalogh, V., MacAskill, M. G., Hadoke, P. W. F., Gray, G. A., & Tavares, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.719031 · Cited by 12
Do Genes Influence Susceptibility to Myocarditis?
Cooper, L. T., & Čiháková, D. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.06.003 · Cited by 8
Self-citationAbbas, H., Broche, L., Ezdoglian, A. A., Li, D., Yuecel, R., Ross, P. J., Cheyne, L., Wilson, H. M., Lurie, D. J., & Dawson, D. K. (2020) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2020.106722 · Cited by 5
Scintigraphic Methods to Evaluate Alterations of Gastric and Esophageal Functions in Female Obesity
Ömür, Ö., Erdoğan, M., Özkılıç, H., & Yılmaz, C. (2014) · Molecular Imaging and Radionuclide Therapy · doi:10.4274/mirt.14633 · Cited by 4 · cited 2×
“Males in both mice and human have elevated levels of CD11b+ immune cells, sera soluble suppression of tumorigenesis-2 (sST2) and Th17-type immune responses during myocarditis [52,61,68,69].”
Background
Research works printed but not linked: 1
- National Heart L. Blood Institute (NHLBI). Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention Workshop- Executive Summary Available online: https://www.nhlbi.nih.gov/events/2021/meeting-challenges-myocarditis-workshop (accessed on 6 January 2022)
Cited by
Drazner, M. H., Bozkurt, B., Cooper, L. T., Aggarwal, N. R., Basso, C., Bhave, N. M., Caforio, A. L. P., Ferreira, V. M., Heidecker, B., Kontorovich, A. R., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.080 · Cited by 249
Autoimmune Myocarditis, Old Dogs and New Tricks.
Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research · doi:10.1161/circresaha.124.323816 · Cited by 51
Self-citationKalinoski, H. M., Daoud, A. R., Rusinkevich, V., Jurčová, I., Talor, M. V., Welsh, R. A., Hughes, D., Zemanová, K., Stříž, I., Hooper, J. E., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2323052121 · Cited by 44
“We chose to research DCM patients since one - third of patients diagnosed with myocarditis develop DCM (42, 48, 49).”
Self-citationSorrentino, U., Gabbiato, I., Canciani, C., Calosci, D., Rigon, C., Zuccarello, D., & Cassina, M. (2023) · Genes · doi:10.3390/genes14030748 · Cited by 17
“Co-occurrence with myocarditis, often of viral origin, has also frequently been described in these patients, possibly acting in a synergistic manner with the structural defect caused by the genetic disorder [7].”
BackgroundMaleszewski, J. J., Banner, J., de Boer, H. H., Gaspari, M. D., Fishbein, M. C., Parsons, S. A., Sampson, B. A., Sheppard, M. N., van der Wal, A. C., Stone, J. R., et al. (2025) · Cardiovascular Pathology · doi:10.1016/j.carpath.2025.107748 · Cited by 18
Metadata
- Authors
- Čiháková, D., Shi, Y., Adhikari, B., Bandettini, W. P., Cunningham, M. W., Danthi, N., Friedrich, M. G., Liu, P., Longacre, L. S., Mann, D. L., Swirski, F. K., Tang, W. H. W., Zhou, G., & Cooper, Jr.
- Affiliations
- Johns Hopkins University (US)
- National Institutes of Health (US)
- University of Oklahoma Health Sciences Center (US)
- McGill University Health Centre (CA)
- University of Ottawa (CA)
- Washington University in St. Louis (US)
- Cardiovascular Research Institute and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Cleveland Clinic (US)
- Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL 32224, USA
- ORCID
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2022-09-27
- Volume
- 11
- Issue
- 19
- Pages
- 5721
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9571285
- OpenAlex
- W4297538840
- Semantic Scholar
- fdce7e0e0456e8d02880e5fd7f232506449ceecf
- Cited by
- 13
- References
- 121
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 2
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (R35HL135752)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
- Keywords
- myocarditis, immune checkpoint inhibitors, immune pathogenesis, social determinants of health, systems biology, artificial intelligence, therapeutic target, prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.